Advertisement
YOU ARE HERE: LAT HomeCollectionsJames M Sweeney
IN THE NEWS

James M Sweeney

FEATURED ARTICLES
BUSINESS
September 28, 1992 | JAMES M. GOMEZ, TIMES STAFF WRITER
James M. Sweeney has been at the helm of Irvine-based McGaw Inc., a distributor and manufacturer of drug delivery products, since 1990. But his health care industry experience dates back to an after-school job he got in a hospital at 15. Sweeney, 50, is one of the founders of the modern home health care system. Sweeney talks with staff writer James M. Gomez about health care trends. His firm's Excel IV bag, an environmentally safe intravenous bag, received national attention when Sen.
ARTICLES BY DATE
BUSINESS
November 24, 1994
An Orange County Superior Court judge granted a stay Wednesday in a $8.5-million civil judgment involving the previous owner of an Irvine-based medical company whom a jury this week decided had violated a verbal contract with a former colleague. A jury ruled that James Sweeney, former chief executive officer of McGaw Inc., owed David Holder $8.5 million because the two agreed to buy McGaw. Sweeney and Holder met while both worked at Baxter Healthcare.
Advertisement
BUSINESS
June 3, 1994
The former chairman of an Irvine medical products company filed a lawsuit Thursday in federal court against the Miami company that acquired it, accusing that company and its chairman of securities fraud, lawyers said. James M. Sweeney alleges in the lawsuit, filed in U.S. District Court in Santa Ana, that IVAX Corp. and Chairman Phillip Frost misrepresented their company's financial condition before it acquired McGaw, a maker of intravenous products, last March.
BUSINESS
December 18, 1993 | Anne Michaud, Times staff writer
Biomedical Market Newsletter in Costa Mesa has added a new feature to its national publication: a monthly award to recognize responsible, ethical and unselfish business acts. "It is my hope that this award will grow to become a positive force in the biomedical industry for encouraging good," said David G. Anast, the publisher. Anast said that the first award, to be announced in the December issue next week, will go to James M. Sweeney, chairman of McGaw Inc.
BUSINESS
June 3, 1994
The former chairman of an Irvine medical products company filed a lawsuit Thursday in federal court against the Miami company that acquired it, accusing that company and its chairman of securities fraud, lawyers said. James M. Sweeney alleges in the lawsuit, filed in U.S. District Court in Santa Ana, that IVAX Corp. and Chairman Phillip Frost misrepresented their company's financial condition before it acquired McGaw, a maker of intravenous products, last March.
BUSINESS
July 28, 1990 | LESLIE BERKMAN, TIMES STAFF WRITER
An investor group headed by health-care executive James M. Sweeney said Friday that it has agreed to acquire McGaw Laboratories in Irvine for $210 million plus other, unspecified considerations. Terms of the deal were not disclosed. McGaw, owned by Boston-based Kendall Corp., is a major manufacturer of intravenous sets, nutritional and pharmacy products, and intravenous system pumps and controllers sold to hospitals and home health-care providers.
BUSINESS
April 5, 1991 | Leslie Berkman and Anne Michaud Times staff writers
McGaw Inc. has been on a roll since the Irvine manufacturer of intravenous-therapy solutions and equipment was acquired last October for $200 million by an investor group led by James M. Sweeney. Sweeney, chairman and chief executive, reported Thursday that the company had landed a $20-million, five-year contract to supply its products to 18 acute-care hospitals owned and operated by the Franciscan Health System of Aston, Pa.
BUSINESS
October 23, 1990 | LESLIE BERKMAN and GREG JOHNSON, TIMES STAFF WRITER
Boston-based Kendall Co. said Monday that it has completed the $200-million sale of Kendall McGaw Laboratories Inc. to an investor group headed by James M. Sweeney and that it has agreed to sell its pharmaceutical unit to a small San Diego firm for $15 million.
BUSINESS
November 24, 1994
An Orange County Superior Court judge granted a stay Wednesday in a $8.5-million civil judgment involving the previous owner of an Irvine-based medical company whom a jury this week decided had violated a verbal contract with a former colleague. A jury ruled that James Sweeney, former chief executive officer of McGaw Inc., owed David Holder $8.5 million because the two agreed to buy McGaw. Sweeney and Holder met while both worked at Baxter Healthcare.
BUSINESS
February 8, 1994 | JAMES M. GOMEZ, TIMES STAFF WRITER
McGaw Inc. said Monday that James Sweeney, who bought the firm in 1990 and arranged its pending sale to a Florida generic drug manufacturer, has resigned his post as chairman and chief executive officer. Sweeney, 52, who took the Irvine-based provider of intravenous products public last year, was replaced by McGaw President Norwick (Wick) Goodspeed "in anticipation of McGaw's merger," the company said. The resignation was effective immediately, said McGaw spokesman Lawrence Watts.
BUSINESS
December 18, 1993 | Anne Michaud, Times staff writer
Biomedical Market Newsletter in Costa Mesa has added a new feature to its national publication: a monthly award to recognize responsible, ethical and unselfish business acts. "It is my hope that this award will grow to become a positive force in the biomedical industry for encouraging good," said David G. Anast, the publisher. Anast said that the first award, to be announced in the December issue next week, will go to James M. Sweeney, chairman of McGaw Inc.
BUSINESS
September 28, 1992 | JAMES M. GOMEZ, TIMES STAFF WRITER
James M. Sweeney has been at the helm of Irvine-based McGaw Inc., a distributor and manufacturer of drug delivery products, since 1990. But his health care industry experience dates back to an after-school job he got in a hospital at 15. Sweeney, 50, is one of the founders of the modern home health care system. Sweeney talks with staff writer James M. Gomez about health care trends. His firm's Excel IV bag, an environmentally safe intravenous bag, received national attention when Sen.
BUSINESS
April 5, 1991 | Leslie Berkman and Anne Michaud Times staff writers
McGaw Inc. has been on a roll since the Irvine manufacturer of intravenous-therapy solutions and equipment was acquired last October for $200 million by an investor group led by James M. Sweeney. Sweeney, chairman and chief executive, reported Thursday that the company had landed a $20-million, five-year contract to supply its products to 18 acute-care hospitals owned and operated by the Franciscan Health System of Aston, Pa.
BUSINESS
October 23, 1990 | LESLIE BERKMAN and GREG JOHNSON, TIMES STAFF WRITER
Boston-based Kendall Co. said Monday that it has completed the $200-million sale of Kendall McGaw Laboratories Inc. to an investor group headed by James M. Sweeney and that it has agreed to sell its pharmaceutical unit to a small San Diego firm for $15 million.
BUSINESS
February 8, 1994 | JAMES M. GOMEZ, TIMES STAFF WRITER
McGaw Inc. said Monday that James Sweeney, who bought the firm in 1990 and arranged its pending sale to a Florida generic drug manufacturer, has resigned his post as chairman and chief executive officer. Sweeney, 52, who took the Irvine-based provider of intravenous products public last year, was replaced by McGaw President Norwick (Wick) Goodspeed "in anticipation of McGaw's merger," the company said. The resignation was effective immediately, said McGaw spokesman Lawrence Watts.
BUSINESS
July 28, 1990 | LESLIE BERKMAN, TIMES STAFF WRITER
An investor group headed by health-care executive James M. Sweeney said Friday that it has agreed to acquire McGaw Laboratories in Irvine for $210 million plus other, unspecified considerations. Terms of the deal were not disclosed. McGaw, owned by Boston-based Kendall Corp., is a major manufacturer of intravenous sets, nutritional and pharmacy products, and intravenous system pumps and controllers sold to hospitals and home health-care providers.
Los Angeles Times Articles
|